Fetal sacrococcygeal teratoma.
The fetus with sacrococcygeal teratoma (SCT) is at high risk for prenatal and perinatal complications. The natural history and pathophysiology of fetal SCT is different than that of postnatally diagnosed SCT, and has only recently been defined. Survival of fetuses with SCT is dependent on anticipation and recognition of pathophysiologic events, and optimal obstetric and surgical management. In a subset of fetuses with SCT, fetal resection of tumor may offer the only hope for survival.
Flake
A W
AW
UCSF Fetal Treatment Center.
D000328:Adult; D002585:Cesarean Section; D003050:Coccyx / Q000002:abnormalities* / Q000000981:diagnostic imaging / Q000601:surgery; D005260:Female; D005313:Fetal Death / Q000209:etiology; D005865:Gestational Age; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D008431:Maternal-Fetal Exchange / Q000502:physiology; D011247:Pregnancy; D011379:Prognosis; D012447:Sacrum / Q000002:abnormalities* / Q000000981:diagnostic imaging / Q000601:surgery; D013125:Spinal Neoplasms / Q000151:congenital* / Q000000981:diagnostic imaging / Q000601:surgery; D013528:Surgical Staplers; D013724:Teratoma / Q000151:congenital* / Q000000981:diagnostic imaging / Q000601:surgery; D016216:Ultrasonography, Prenatal